Menopause Open Access Articles
Population-based, epidemiologic studies of
menopausal women have recently been conducted and are yielding reliable and consistent
information about the incidence, prevalence, and severity of several menopausal symptoms. However, the field is relatively new, and it is likely that there are subsets of women who are more or less vulnerable to particular symptoms or sets of symptoms. In 2005, a state-of-the-science conference on menopausal symptoms was convened, with a worldwide panel of expert evaluators who were tasked with determining which among the large set of midlife symptoms are most likely to be due to
menopause. Symptoms were evaluated for their proximity to menopause, apart from the
aging process, and the likelihood that
estrogen is effective in relieving symptoms. Based on this evidence review, 3 symptoms emerged as having good evidence for linkage to menopause: vasomotor symptoms, vaginal dryness/dyspareunia, and difficulty sleeping/insomnia. After this conference and based on 3 seminal studies, adverse mood/depression was added to the list. Adequate longitudinal studies on cognitive function during the menopause were not yet available but have also become subsequently widely reported. It is clear that there are many other symptoms that are reported by menopausal women. These include joint and muscle aches, changes in body contour, and increased skin wrinkling.1 Several studies have examined the associations between these symptoms and
menopause. Given the methods of ascertainment, the subjective nature of the complaints, the likelihood that there is publication bias (wherein positive studies demonstrating linkage to menopause are more likely to be published than negative studies), and their variation over time, it has been difficult to establish a true relationship between these symptoms and
menopause. Other symptoms, such as
urinary incontinence (UI) and sexual function, have mixed data for efficacy of
estrogen treatment and linkage to menopause, apart from the
aging process. For these reasons, this article addresses the core 4 symptoms and includes cognitive issues because they are of great importance and concern to
aging women.
High Impact List of Articles
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
The importance of budgeting in clinical trials and how a budget can prevent billing errors
Mitchell Appleson
Editorial: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Newly available treatments for epilepsy: review of clinical studies of lacosamide, ezogabine, perampanel and eslicarbazepine acetate
Steve S Chung
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 3
Acknowledgements: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical and experimental data on the use of laquinimod for the treatment of multiple sclerosis
De-Hyung Lee, Ralf A Linker
Review: Clinical Trail Outcomes: Clinical Investigation
Relevant Topics in Clinical